AKT protein kinase inhibitors

摘要

Disclosed are compounds of formula A-L-CR, wherein A is a group G-B1-W-(-B2NR13R14)-C(=O)- or G-B1-W-(-B2NR13R14)-CH2-C(=O)- as depicted; CR is a pyrrolopyridine, and L is as defined in the specification. The compounds are AKT protein kinase inhibitors useful for the treatment of hyperproliferative diseases such as cancer.